Relaxin: Completed double-blind, placebo-controlled Phase I testing, with the product determined to be safe in 30 patients treated with escalating doses. Result

Connective Therapeutics Inc., Palo Alto Product: Relaxin, a protein hormone secreted in pregnancy that remodels connective tissue Indication: Scleroderma Status: Completed double-blind, placebo-contr...